Concepts (71)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Triamcinolone | 1 | 2020 | 14 | 0.700 |
Why?
|
| Hydropneumothorax | 1 | 2020 | 1 | 0.690 |
Why?
|
| Pyelonephritis | 1 | 2020 | 26 | 0.690 |
Why?
|
| Asbestos | 1 | 2020 | 14 | 0.690 |
Why?
|
| Mycophenolic Acid | 1 | 2020 | 51 | 0.680 |
Why?
|
| Thoracic Neoplasms | 1 | 2020 | 36 | 0.680 |
Why?
|
| Dermatitis, Atopic | 1 | 2020 | 41 | 0.670 |
Why?
|
| Pleural Neoplasms | 1 | 2020 | 42 | 0.660 |
Why?
|
| Mesothelioma | 1 | 2020 | 54 | 0.650 |
Why?
|
| Emphysema | 1 | 2020 | 66 | 0.650 |
Why?
|
| Blister | 1 | 2018 | 19 | 0.610 |
Why?
|
| Fingers | 1 | 2018 | 65 | 0.590 |
Why?
|
| Staphylococcus aureus | 1 | 2018 | 456 | 0.470 |
Why?
|
| Staphylococcal Infections | 1 | 2018 | 552 | 0.420 |
Why?
|
| Diagnosis, Differential | 4 | 2020 | 1877 | 0.360 |
Why?
|
| Lung Neoplasms | 1 | 2020 | 1582 | 0.340 |
Why?
|
| Cardiovascular Diseases | 3 | 2025 | 1863 | 0.300 |
Why?
|
| Kidney Failure, Chronic | 2 | 2022 | 865 | 0.210 |
Why?
|
| American Heart Association | 1 | 2025 | 295 | 0.210 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2020 | 2056 | 0.200 |
Why?
|
| Cardiology | 2 | 2024 | 472 | 0.190 |
Why?
|
| Anticholesteremic Agents | 1 | 2023 | 230 | 0.180 |
Why?
|
| Histoplasma | 1 | 2020 | 28 | 0.180 |
Why?
|
| Antibodies, Fungal | 1 | 2020 | 16 | 0.180 |
Why?
|
| Itraconazole | 1 | 2020 | 25 | 0.180 |
Why?
|
| Lymphoma, T-Cell, Cutaneous | 1 | 2020 | 7 | 0.180 |
Why?
|
| Histoplasmosis | 1 | 2020 | 46 | 0.170 |
Why?
|
| Lymphadenopathy | 1 | 2020 | 30 | 0.170 |
Why?
|
| Multimorbidity | 1 | 2020 | 20 | 0.170 |
Why?
|
| Administration, Topical | 1 | 2020 | 143 | 0.170 |
Why?
|
| Hemodialysis, Home | 1 | 2019 | 13 | 0.160 |
Why?
|
| Immunocompetence | 1 | 2018 | 33 | 0.150 |
Why?
|
| Choice Behavior | 1 | 2019 | 134 | 0.150 |
Why?
|
| Neoplasm Invasiveness | 1 | 2020 | 603 | 0.150 |
Why?
|
| Glucocorticoids | 1 | 2020 | 378 | 0.140 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2023 | 714 | 0.140 |
Why?
|
| Drainage | 1 | 2018 | 256 | 0.130 |
Why?
|
| Patient Education as Topic | 1 | 2019 | 451 | 0.130 |
Why?
|
| Kidney Transplantation | 1 | 2020 | 628 | 0.120 |
Why?
|
| Recurrence | 1 | 2018 | 1422 | 0.110 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2022 | 715 | 0.110 |
Why?
|
| Middle Aged | 4 | 2020 | 25992 | 0.110 |
Why?
|
| Humans | 10 | 2025 | 123163 | 0.110 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 6371 | 0.070 |
Why?
|
| Treatment Outcome | 2 | 2020 | 12129 | 0.060 |
Why?
|
| Female | 4 | 2020 | 65489 | 0.060 |
Why?
|
| Male | 3 | 2020 | 60082 | 0.060 |
Why?
|
| Europe | 1 | 2024 | 374 | 0.060 |
Why?
|
| Congresses as Topic | 1 | 2024 | 170 | 0.050 |
Why?
|
| Proprotein Convertase 9 | 1 | 2023 | 67 | 0.050 |
Why?
|
| Aged | 1 | 2020 | 19080 | 0.050 |
Why?
|
| Societies, Medical | 1 | 2024 | 678 | 0.040 |
Why?
|
| Antigens, Fungal | 1 | 2020 | 34 | 0.040 |
Why?
|
| Radiography, Abdominal | 1 | 2020 | 47 | 0.040 |
Why?
|
| Cholesterol, LDL | 1 | 2023 | 557 | 0.040 |
Why?
|
| Radiography, Thoracic | 1 | 2020 | 156 | 0.040 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2020 | 224 | 0.040 |
Why?
|
| Immunocompromised Host | 1 | 2020 | 300 | 0.040 |
Why?
|
| Antifungal Agents | 1 | 2020 | 293 | 0.040 |
Why?
|
| United States | 2 | 2025 | 10631 | 0.030 |
Why?
|
| Renal Dialysis | 1 | 2022 | 842 | 0.030 |
Why?
|
| Decision Making | 1 | 2019 | 651 | 0.030 |
Why?
|
| Delivery of Health Care | 1 | 2019 | 607 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2022 | 3666 | 0.030 |
Why?
|
| Relaxation | 1 | 1971 | 2 | 0.020 |
Why?
|
| Community Mental Health Services | 1 | 1971 | 38 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2019 | 6032 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2020 | 3013 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2019 | 16021 | 0.010 |
Why?
|
| Social Adjustment | 1 | 1971 | 85 | 0.010 |
Why?
|
| Texas | 1 | 1971 | 3555 | 0.000 |
Why?
|